Case Studies in Locally Advanced Pancreatic Cancer

Slides:



Advertisements
Similar presentations
Fostering a Collaborative Approach in the Management of BRCA-Mutated Ovarian Cancer.
Advertisements

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
The Nurse View: Management of Pancreatic Cancer
New Horizons for SMA.
The Nurse View.
Systemic Lupus Erythematosus
Current Management and Future Options for Tardive Dyskinesia
Advances in Managing Inhibitors in Patients With Hemophilia A
Updates on Emerging GLP-1 Receptor Agonists
Applying New Data in Practice:
Progression After Cancer Immunotherapy in Advanced NSCLC
The HCV Revolution: Are You and Your Practice Ready?
Expert Perspectives on Best Practices for Diagnosis and Management of Spinal Muscular Atrophy.
New Standards of Care in ALK-Translocated Advanced NSCLC
Induction Chemotherapy for Patients With High-Risk or Secondary AML
Determining the Best Treatment Algorithm for Patients With Head and Neck Cancer.
The Resurgence of Topical Treatments Across a Spectrum of Psoriasis
Navigating the Data and Evolving Our Approach
Emerging Targeted Agents for Relapsed/Refractory Non-Hodgkin Lymphoma
Addressing Disease Burden in Asthma
The Evolving Role of Immunotherapy in NSCLC
Immunotherapy in Pancreatic Cancer: Thinking Outside the Box
Optimizing Management of Advanced Bladder Cancer
The Emerging Role of Immunotherapy in Hodgkin Lymphoma
Evaluating Next-Generation BTK Inhibitors
Case Studies in Unresectable Hepatocellular Carcinoma
Navigating New Oral Treatment Algorithms in CLL
Essential Concepts in the Use of Immunotherapies in Bladder Cancer
Immunotherapy for cSCC
Advancing Care in Genitourinary Cancer: Perspectives From Chicago
New Data on Emerging Treatments for Psoriasis
Advancing Care Across the Spectrum of Pancreatic Cancer
Nurse View: Practice Pearls in Advanced Pancreatic Adenocarcinoma
Personalizing Management in the Care of Patients With Advanced Sarcoma
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Talking With Your Patients About Excessive Sweating
Advances in Immunotherapy for Peanut Allergy
Immune Checkpoint Inhibitors in Lung Cancer
Locally Advanced Lung Cancer
Tackling Schizophrenia With Your Patients
Advances in Gastrointestinal Cancers
Guide to Atopic Dermatitis
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
The Rising Cost of Healthcare and Potential Impact of Biosimilars
Treatment of Locally Advanced Pancreatic Cancer
Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC
Patient Questions and Expert Answers in Psoriasis:
Management of Advanced Pancreatic Adenocarcinoma
Are We Making Progress in the Management of Huntington Disease?
All for One: Multidisciplinary Management in EGFR-Mutated NSCLC
The Psychiatrist's Role in Tardive Dyskinesia
Managing CLL With BTK Inhibitors
Novel Concepts in the Management of RCC
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data.
Peanut Allergy Immunotherapy
From Adjuvant to Metastatic in Melanoma
The ABCs of Pharmacogenomics in Clinical Practice
The Psychiatrist's Role in Tardive Dyskinesia
Peanut Allergy Immunotherapy
Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition
This program will include a discussion of off-label treatment or use of investigational agents not approved by the FDA for use in the US, and data that.
Checkpoint Inhibitors in First-Line Advanced NSCLC
Peanut Allergy Immunotherapy
The Acne Landscape Is Evolving
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Moving Care Forward in Advanced Gastric Cancer
Finding the Right Sequence in Patients With EGFR-Mutated NSCLC
Immune Checkpoint Inhibitors in Lung Cancer
A New Era in Migraine Prevention
Meet the JAKs.
Presentation transcript:

Case Studies in Locally Advanced Pancreatic Cancer

This program will include a discussion of data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.

Pancreatic Adenocarcinoma

LAPC

Case Study Presentation

ASCO® Guidelines for Locally Advanced, Unresectable Pancreatic Adenocarcinoma

Phase 2 SCALOP Trial Study Design

SCALOP Trial Efficacy (Long-Term Follow-Up)

Phase 3 LAP07 Trial Study Design

LAP07 Trial Efficacy in Gemcitabine-Only Arm

Phase 2 LAPACT Trial Study Design

LAPACT Trial Efficacy

FOLFIRINOX for LAPC

Select Clinical Trials for LAPC

Emerging Role for SBRT in LAPC

How Long Do We Treat Our Patients For?

Genetic Profiling in Pancreatic Cancer

Palliative Care and Symptom Management

Concluding Remarks

Abbreviations